Sharescart Research Club logo

TCM Overview

TCM Ltd. is an Indian company engaged in the manufacturing, trading, and supply of industrial and consumer products. Its offerings typically include machinery components, engineering goods, and materials used across sectors such as manufacturing, construction, and infrastructure. The company emphasizes quality production, adherence to industry standards, and precision engineering to ensure durable and reliable products. TCM Ltd. leverages modern manufacturing techniques, skilled workforce, and efficient supply chain management to maintain cons...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

TCM Key Financials

Market Cap ₹33 Cr.

Stock P/E 23.9

P/B 1.3

Current Price ₹44.8

Book Value ₹ 35.2

Face Value 10

52W High ₹81

Dividend Yield 0%

52W Low ₹ 36.5

TCM Share Price

₹ | |

Volume
Price

TCM Quarterly Price

Show Value Show %

TCM Peer Comparison

TCM Quarterly Results

#(Fig in Cr.) Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 5 11 9 5 7 6 8 3 6 6
Other Income 0 0 0 0 0 0 4 0 1 0
Total Income 5 11 9 5 7 6 12 3 7 6
Total Expenditure 7 11 9 6 7 7 8 5 7 6
Operating Profit -2 1 -0 -1 -1 -1 4 -2 -0 -0
Interest 0 0 0 0 0 0 0 0 0 1
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -2 1 -0 -1 -1 -1 4 -2 -1 -1
Provision for Tax 0 0 0 0 0 0 -0 -0 0 0
Profit After Tax -2 1 -0 -1 -1 -1 4 -2 -1 -1
Adjustments 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments -2 1 -0 -1 -1 -1 4 -2 -1 -1
Adjusted Earnings Per Share -2.2 1 -0.5 -1.3 -0.8 -1.2 5.4 -3 -1 -1.5

TCM Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 0 1 4 4 7 32 26 23
Other Income 0 1 1 1 0 0 4 5
Total Income 0 2 5 4 7 33 30 28
Total Expenditure 1 2 5 8 11 34 28 26
Operating Profit -1 0 0 -3 -4 -2 2 2
Interest 0 0 0 0 0 0 1 1
Depreciation 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 -3 0 0 0 0
Profit Before Tax -1 0 0 -6 -4 -2 1 0
Provision for Tax 0 0 0 -0 -0 0 -0 0
Profit After Tax -1 0 0 -6 -4 -2 1 0
Adjustments 0 0 0 1 0 0 0 0
Profit After Adjustments -1 0 0 -5 -4 -2 2 0
Adjusted Earnings Per Share -1.7 0.6 0.2 -9.4 -5.4 -2.6 2.2 -0.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -19% 87% 92% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 12% 10% 4% 2%
ROE Average 5% -6% -4% -3%
ROCE Average 6% -5% -27% -20%

TCM Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 32 32 33 25 31 29 31
Minority's Interest 0 0 0 -1 -1 -1 -1
Borrowings 0 0 0 0 0 0 0
Other Non-Current Liabilities 20 20 20 20 20 20 0
Total Current Liabilities 17 13 15 17 19 36 47
Total Liabilities 69 65 68 61 69 84 76
Fixed Assets 58 58 59 55 36 17 9
Other Non-Current Assets 2 2 3 2 4 1 7
Total Current Assets 9 5 6 5 9 45 42
Total Assets 69 65 68 61 69 84 76

TCM Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 0 4 0 0 0 0 0
Cash Flow from Operating Activities -2 -1 0 -4 -11 2 -10
Cash Flow from Investing Activities 0 0 -1 4 6 -1 -0
Cash Flow from Financing Activities 5 -3 0 0 5 -1 10
Net Cash Inflow / Outflow 4 -4 0 0 -0 0 0
Closing Cash & Cash Equivalent 4 0 0 0 0 0 0

TCM Ratios

# Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) -1.74 0.56 0.22 -9.43 -5.35 -2.61 2.16
CEPS(Rs) -1.73 0.57 0.27 -10.47 -5.21 -2.66 2.34
DPS(Rs) 0 0 0 0 0 0 0
Book NAV/Share(Rs) -53.17 -51.87 -51.65 46.49 41.11 38.5 40.81
Core EBITDA Margin(%) -218.08 -90.44 -19.16 -112.59 -49.94 -6.91 -8.25
EBIT Margin(%) -208.51 33.73 9.16 -165.08 -54.71 -6.5 7.58
Pre Tax Margin(%) -239.33 33.1 8.87 -165.46 -58.46 -6.98 5.25
PAT Margin (%) -239.33 33.1 2.79 -165.4 -58.14 -7.1 5.38
Cash Profit Margin (%) -238.35 33.71 3.51 -160.53 -53.07 -6.18 6.73
ROA(%) -1.37 0.45 0.18 -9.1 -6.56 -3 1.75
ROE(%) 0 0 0 0 -15.24 -7.69 4.72
ROCE(%) 0 0 0 -123.47 -12.55 -6.84 5.57
Receivable days 1393.38 653.71 184.76 226.81 163.72 74.74 107.2
Inventory Days 1565.51 636.24 168.31 193.84 127.99 194.58 414.19
Payable days 2568.13 1784.19 703.75 306.95 57.75 32.26 53.44
PER(x) 0 0 115 0 0 0 16.58
Price/Book(x) -0.56 0 -0.48 0.65 0.81 1.43 0.88
Dividend Yield(%) 0 0 0 0 0 0 0
EV/Net Sales(x) 45.17 9.81 4.56 6.4 3.54 1.27 1.44
EV/Core EBITDA(x) -21.77 28.58 46.09 -7.3 -7.12 -22.74 16.16
Net Sales Growth(%) 0 132.34 361.81 -16.36 106.71 338.67 -19.32
EBIT Growth(%) 0 137.58 25.42 -1607.27 31.5 47.91 194.19
PAT Growth(%) 0 132.13 -61.13 -5065.54 27.34 46.41 161.13
EPS Growth(%) 0 132.08 -61.13 -4444.94 43.2 51.3 182.65
Debt/Equity(x) -0.19 -0.2 -0.21 0.26 0.05 0.01 0.37
Current Ratio(x) 0.51 0.38 0.39 0.26 0.5 1.25 0.9
Quick Ratio(x) 0.41 0.27 0.24 0.18 0.3 0.41 0.29
Interest Cover(x) -6.76 53.52 31.4 -434.65 -14.59 -13.47 3.25
Total Debt/Mcap(x) 0.33 0 0.43 0.4 0.06 0.01 0.42

TCM Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 49.51 49.51 49.51 49.51 49.51 49.51 49.51 49.51 49.51 49.51
FII 0 0 0 0 0 0 0 0 0 0
DII 7.71 7.71 7.44 7.44 7.44 7.44 7.44 7.44 7.44 7.44
Public 42.78 42.78 43.05 43.05 43.05 43.05 43.05 43.05 43.05 43.05
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

TCM News

TCM Pros & Cons

Pros

  • Company is almost debt free.

Cons

  • Promoter holding is low: 49.51%.
  • Company has a low return on equity of -6% over the last 3 years.
  • Debtor days have increased from 32.26 to 53.44days.
whatsapp